Key Events This Week
27 Jan: New 52-week low (Rs.77.15)
28 Jan: Strong gap up and intraday high (Rs.83.40)
29 Jan: Price retraces to Rs.79.20 (-1.98%)
30 Jan: Week closes at Rs.80.50 (+1.64%)
Feb 03
BSE+NSE Vol: 1.04 lacs

Themis Medicare Ltd recorded a robust intraday performance on 3 Feb 2026, surging 7.03% to touch a day’s high of Rs 84.99, significantly outperforming its sector and the broader market amid mixed market conditions.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news article
Themis Medicare Ltd witnessed a robust start to the trading session on 3 Feb 2026, opening with a notable gap up of 9.59%, signalling renewed positive momentum after two consecutive days of decline. This surge outpaced the Pharmaceuticals & Biotechnology sector’s gain of 2.73%, underscoring a distinct shift in market sentiment towards the stock.
Read full news article
Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.76 today, marking a significant decline in its stock price amidst ongoing downward momentum and underperformance relative to the broader market and sector indices.
Read full news article
27 Jan: New 52-week low (Rs.77.15)
28 Jan: Strong gap up and intraday high (Rs.83.40)
29 Jan: Price retraces to Rs.79.20 (-1.98%)
30 Jan: Week closes at Rs.80.50 (+1.64%)

Themis Medicare Ltd commenced trading with a significant gap up, opening 6.85% higher than its previous close, signalling a robust start amid positive market sentiment. This upward move outpaced the Pharmaceuticals & Biotechnology sector by 2.86%, marking a notable shift after two consecutive days of decline.
Read full news article
Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.77.15 today, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.
Read full news article
Themis Medicare Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.78.7 today, marking a significant decline in its stock price amid ongoing financial headwinds and subdued market performance.
Read full news article
Themis Medicare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 15 February 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleThemis Medicare Limited has informed the Exchange regarding 'Newspaper Advertisement for Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2019.'.
Themis Medicare Limited has informed the Exchange regarding Grant of 20000 Options under 'Themis Medicare ESOS 2012'.
Themis Medicare Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019.'.
No Upcoming Board Meetings
Themis Medicare Ltd has declared 50% dividend, ex-date: 04 Sep 25
Themis Medicare Ltd has announced 1:10 stock split, ex-date: 10 Oct 23
No Bonus history available
No Rights history available